Share this article
Share this article
TEL AVIV, Israel, Dec. 22, 2020 /PRNewswire/ Today (Tuesday) the Tel Aviv Stock Exchange announces (TASE: TASE) TASE UP s first two listings - venture capital fund, Group 11 and start-up company, Veev.
TASE UP, launched several months ago, is an electronic platform designed by TASE to allow private high-tech companies, venture capital funds, funds specializing in real estate properties overseas and credit funds access to investments from institutional and accredited investors. Unlike listing on TASE main market, companies that are listed on TASE UP platform remain private and are not subject to any reporting or prospectus publishing requirements under the Israeli Securities Law.
Ittai Ben Zeev, TASE CEO: This year marked a significant milestone in the strengthening of ties between TASE and local high-tech, as a record number of new technology companies joined TASE, with dozens more to come. Our strategy over the past few years has laid the foundation that allows TASE to better reflect the success of the Israeli high-tech and serve as a home for those companies.
This year, more than ever, local companies across sectors sought TASE for capital raising and growth, and attracted great interest from both local investors and global players. As home of the Israeli economy, we believe that TASE is the natural venue for the Israeli companies, institutional investors and the public and expect to see the growth trend continue into the coming years.
Share:
ABU DHABI, UAE and TEL AVIV, Israel, Dec. 16, 2020 /PRNewswire/ Abu Dhabi Securities Exchange (ADX) and the Tel Aviv Stock Exchange (TASE: TASE) have, today, signed a memorandum of understanding (MOU), the first time an Arab exchange has entered into a commercial relationship with the state of Israel. The MOU will facilitate the development of channels of communication to foster co-operation between the two exchanges, and contribute to the growth of the capital markets in the United Arab Emirates and Israel.
The MOU was formally signed today by H.E. Mohamed Ali Al Shorafa Al Hammadi, Chairman of ADX, and Amnon Neubach, Chairman of TASE, at a virtual signing ceremony. A video of the event can be viewed here https://youtu.be/zX8Gn-u6SH0.
Study: New Intervention Helps with Alcohol-related Cognitive Impairment
Study: New Intervention Helps with Alcohol-related Cognitive Impairment
SAN FRANCISCO, Dec. 14, 2020 Researchers at Yale published positive results from a pilot study of a novel combination therapy in patients with Mild Cognitive Impairment related to Alcohol Use. The therapy used the drug Donepezil in combination with the brain training BrainHQ from Posit Science.
In their report in the journal Substance Abuse, the researchers note that Alcohol Use Disorders (AUDs) significantly impact public health, cost billions of dollars annually, and are prevalent in Veterans. The Veterans in this study also were diagnosed with Mild Cognitive Impairment (MCI), a pre-dementia condition. AUD contributes to Alzheimer’s risk, and MCI worsens the cognitive abilities for self-regulation setting the stage for a downward spiral. AUD-related MCI (AUD-MCI) is a medical classification for which there is no evidence-based tre